These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1283495)

  • 1. Localization of basic fibroblast growth factor (bFGF) in a metastatic cell line (AT-3) established from the Dunning prostatic carcinoma of rat: application of a specific monoclonal antibody.
    Nishikawa K; Yoshitake Y; Minemura M; Yamada K; Matuo Y
    Adv Exp Med Biol; 1992; 324():131-9. PubMed ID: 1283495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In situ assay of basic fibroblast growth factor in cultured cells with a specific monoclonal antibody.
    Minemura M; Yoshitake Y; Matsuzaki K; Watanabe A; Nishikawa K
    Cell Struct Funct; 1993 Oct; 18(5):333-43. PubMed ID: 7513265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stromal-epithelial paracrine interactions in the neoplastic rat and human prostate.
    Djakiew D; Pflug B; Onoda M
    Adv Exp Med Biol; 1993; 330():185-202. PubMed ID: 8368133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rat prostate cancer cell line-specific production and apparent secretion of heparin-binding growth factors.
    Shain SA; Ke LD; Wong G; Karaganis AG
    Cell Growth Differ; 1992 Apr; 3(4):249-58. PubMed ID: 1381214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (125)I-labeled anti-bFGF monoclonal antibody inhibits growth of hepatocellular carcinoma.
    Hu PH; Pan LH; Wong PT; Chen WH; Yang YQ; Wang H; Xiang JJ; Xu M
    World J Gastroenterol; 2016 Jun; 22(21):5033-41. PubMed ID: 27275095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of modulation of basic fibroblast growth factor on tumor growth in vivo.
    Gross JL; Herblin WF; Dusak BA; Czerniak P; Diamond MD; Sun T; Eidsvoog K; Dexter DL; Yayon A
    J Natl Cancer Inst; 1993 Jan; 85(2):121-31. PubMed ID: 8418301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibodies directed against basic fibroblast growth factor which inhibit its biological activity in vitro and in vivo.
    Reilly TM; Taylor DS; Herblin WF; Thoolen MJ; Chiu AT; Watson DW; Timmermans PB
    Biochem Biophys Res Commun; 1989 Oct; 164(2):736-43. PubMed ID: 2479375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of high-molecular-mass forms of basic fibroblast growth factor produced by hepatocellular carcinoma cells: possible involvement of basic fibroblast growth factor in hepatocarcinogenesis.
    Shimoyama Y; Gotoh M; Ino Y; Sakamoto M; Kato K; Hirohashi S
    Jpn J Cancer Res; 1991 Nov; 82(11):1263-70. PubMed ID: 1721615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basic fibroblast growth factor in human prostate cancer cells.
    Nakamoto T; Chang CS; Li AK; Chodak GW
    Cancer Res; 1992 Feb; 52(3):571-7. PubMed ID: 1732045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corneal endothelial modulation: a factor released by leukocytes induces basic fibroblast growth factor that modulates cell shape and collagen.
    Kay EP; Gu X; Ninomiya Y; Smith RE
    Invest Ophthalmol Vis Sci; 1993 Mar; 34(3):663-72. PubMed ID: 8449685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Derivation of monoclonal antibody to basic fibroblast growth factor and its application.
    Yoshitake Y; Matsuzaki K; Nishikawa K
    Methods Enzymol; 1991; 198():148-57. PubMed ID: 1857216
    [No Abstract]   [Full Text] [Related]  

  • 12. A link between basic fibroblast growth factor (bFGF) and EWS/FLI-1 in Ewing's sarcoma cells.
    Girnita L; Girnita A; Wang M; Meis-Kindblom JM; Kindblom LG; Larsson O
    Oncogene; 2000 Aug; 19(37):4298-301. PubMed ID: 10980604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different antitumor activities of anti-bFGF neutralizing antibodies: heparin-binding domain provides an inefficient epitope for neutralization in vivo.
    Aonuma M; Yoshitake Y; Nishikawa K; Tanaka NG
    Anticancer Res; 1999; 19(5B):4039-44. PubMed ID: 10628351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of solid tumor growth by immunoneutralizing monoclonal antibody against human basic fibroblast growth factor.
    Hori A; Sasada R; Matsutani E; Naito K; Sakura Y; Fujita T; Kozai Y
    Cancer Res; 1991 Nov; 51(22):6180-4. PubMed ID: 1718597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibodies against heparin-binding growth factor II/basic fibroblast growth factor that block its biological activity: invalidity of the antibodies for tumor angiogenesis.
    Matsuzaki K; Yoshitake Y; Matuo Y; Sasaki H; Nishikawa K
    Proc Natl Acad Sci U S A; 1989 Dec; 86(24):9911-5. PubMed ID: 2481318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential growth factor production, secretion, and response by high and low metastatic variants of B16BL6 melanoma.
    Blanckaert VD; Schelling ME; Elstad CA; Meadows GG
    Cancer Res; 1993 Sep; 53(17):4075-81. PubMed ID: 8358737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Culture-induced increase in acidic and basic fibroblast growth factor activities and their association with the nuclei of vascular endothelial and smooth muscle cells.
    Speir E; Sasse J; Shrivastav S; Casscells W
    J Cell Physiol; 1991 May; 147(2):362-73. PubMed ID: 1710230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast growth factors: an epigenetic mechanism of broad spectrum resistance to anticancer drugs.
    Song S; Wientjes MG; Gan Y; Au JL
    Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8658-63. PubMed ID: 10890892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of multiple species of basic fibroblast growth factor mRNA and protein in normal and tumor-derived mammary epithelial cells in culture.
    Li S; Shipley GD
    Cell Growth Differ; 1991 Apr; 2(4):195-202. PubMed ID: 1678277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expressions of basic fibroblast growth factor and its receptors and their relationship to proliferation of human hepatocellular carcinoma cell lines.
    Ogasawara S; Yano H; Iemura A; Hisaka T; Kojiro M
    Hepatology; 1996 Jul; 24(1):198-205. PubMed ID: 8707262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.